Name: Tumor Suppressor Par-4: Role in Cancer and Other Diseases (en Inglés)
SKU: 57465178
Price: 3253.66 MXN
Availability: InStock
Author: Rangnekar, Vivek M.
ISBN: 9783030805579

portada Tumor Suppressor Par-4: Role in Cancer and Other Diseases (en Inglés)

Tumor Suppressor Par-4: Role in Cancer and Other Diseases (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

Rangnekar, Vivek M.

Idioma

Inglés

N° páginas

331

Encuadernación

Tapa Dura

Dimensiones

29.1x21.5x2.2 cm

Peso

1.16 kg.

ISBN13

9783030805579

Categorías

Oncología

Tumor Suppressor Par-4: Role in Cancer and Other Diseases (en Inglés)

Rangnekar, Vivek M. (Autor) · Springer · Tapa Dura

Libro Nuevo Importado

Envío: 17 a 22 días háb.

$ 5,915.74$ 3,253.66

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 3,253.66

¡Envío Gratis! Llega entre el 17 Sep y el 25 Sep a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Tumor Suppressor Par-4: Role in Cancer and Other Diseases (en Inglés)"

Par-4 is a naturally occurring tumor suppressor. Studies have indicated that overexpression of Par-4 selectively induces apoptosis in cancer cells while leaving normal, health, cells unaffected. Mechanisms contributing to this cancer-selective action of Par-4 have been associated with PKA activation of intracellular Par-4 in cancer cells or GRP78 expression primarily on the surface of cancer cells. On the other hand, endogenous Par-4 sensitizes cells to the action of a broad range of apoptotic inducers acting via the extrinsic and intrinsic pathways. A number of binding partners of Par-4 have been identified and shown to regulate Par-4 function in cancer and other diseases, such as Alzheimer's and major depression. Recent studies have recognized a number of natural products, dietary supplements, synthetic molecules and FDA-approved drugs that induce the secretion of Par-4 protein to cause apoptosis in primary or metastatic tumors, one of which is in clinical trials. More than 50 different laboratories worldwide are involved in Par-4 based research of this unique protein that has progressed from the bench to clinical trials. This second, companion volume will provide a comprehensive overview of Par-4's role in cancer and other diseases. Chapters are written by leading researchers, and will be useful for a broad audience across the scientific community, particularly students and trainees, who are the next generation of scientists and clinicians to participate in new studies and discoveries on Par-4.